Fascioliasis
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis (NCT06367361) | Universidad Peruana Cayetano Heredia | 2026-08-15 |
| Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). (NCT04230148) | Novartis Pharmaceuticals | 2022-02-11 |
| Parasitological Evaluation of Fascioliasis in Clinically Suspected Patients . (NCT03869788) | Assiut University | 2019-09-01 |
Track Fascioliasis automatically
Every clearance here is in the API, with alerts when new ones post.